Carbonic anhydrase IX (CA IX) is a transmembrane enzyme overexpressed in various tumor types, including renal cell carcinoma, malignant melanoma, non-small cell lung cancer, and breast cancer. This evidence concerns the gene CA9 and hereditary clear cell renal cell carcinoma.